Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030201 (
Postoperative pain
)
1,085
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Based on the authors' review of the literature on pediatric postoperative pain assessment with special attention to groups of vulnerable infants, this article (1) reports on type of surgery and its relationship to postoperative pain intensity; (2) reviews the characteristics of existing postoperative pain instruments for neonates, infants, and toddlers; (3) discusses timing, duration, and who should assess postoperative pain; (4) reviews the specific literature on pain assessment in critically ill infants, including the extremely low birth weight and the cognitively and/or neurologically impaired infant, and (5) discusses the role of parents in postoperative pain assessment.
Postoperative pain
instruments are useful for specific groups of vulnerable infants, but it is important that in addition to the valuable scoring of pain, common sense is used and factors such as developmental stage, temperament and personality, number of previous painful experiences, anxiety, and environmental factors are taken into account.
Clin Perinatol 2002
Sep
PMID:Are postoperative pain instruments useful for specific groups of vulnerable infants? 1238 Apr 70
This prospective, double-blind, randomized, controlled trial was performed to evaluate the antiemetic effectiveness and side effects of adding droperidol to morphine delivered via a patient-controlled analgesia (PCA) device in 94 women undergoing transabdominal hysterectomy with a standardized anesthetic regimen. They were randomly allocated to receive postoperative PCA as either bolus doses of morphine I mg or a combination of morphine 1 mg and 0.0625 mg droperidol with a lockout interval of 5 minutes and no continuous infusion. The incidence of nausea 6-18 hours postoperatively and 18-24 hours postoperatively was significantly lower in the morphine and droperidol group than in the morphine only group and its severity 2-6 hours, 6-18 hours, and 18-24 hours postoperatively was significantly lower. The number needed to treat to prevent nausea comparing the morphine only group at 6-18 and at 18-24 hours postoperatively were 4 and 4 (95% CI 2-27 and 2-11, respectively). The amount of morphine used 6-18 hours postoperatively in the droperidol group was lower than in the morphine only group. Although the incidence of vomiting and the amount of rescue antiemetics were lower in the morphine and droperidol group, the difference was not statistically significant.
Postoperative pain
scores were not different between the groups. No patients were oversedated. A series of extrapyramidal reactions were observed in one patient in the morphine and droperidol group. The drug and consumable item cost was not different between the groups. We conclude that droperidol added to morphine in PCA reduces nausea. The appropriate dose of droperidol should be further investigated to reduce the incidence of vomiting.
J Med Assoc Thai 2002
Sep
PMID:Adding droperidol to morphine patient-controlled analgesia: effect on nausea and vomiting. 1245 31
Following penile surgery, erections are painful and may prejudice the result, because the sutures may not withstand a rigid erection. Therefore, prevention of erection and management of pain are extremely important following hypospadias repair, especially in adult patients. In this prospective study, we aimed to achieve these goals by using an epidural block with patient-controlled analgesia. We allocated 20 adult patients scheduled for hypospadias repair randomly either to receive or not to receive epidural analgesia.
Postoperative pain
was scored according to a standardised scoring system, based on a 10 point visual analogue scale. In group I (n = 10), analgesia was provided by a 3 ml h(-1) continuous infusion of fentanyl (2 microg) and bupivacaine solution (0.125%) in 1 ml saline via an epidural catheter for the first 3 days. Patient-controlled epidural analgesia was administered with an additional 5 ml of the same solution when the pain score was high (> 4). After 3 days, fentanyl was excluded from the treatment protocol, and analgesia was maintained with bupivacaine (0.125%). In group II (n = 10, control group), an epidural catheter was not inserted, and analgesia was maintained with pethidine (1 mg kg(-1)). Pain management was found to be more effective in group I. No erections occurred in group I, but the erection rate in group II was mean +/- s.d. = 1.7 +/- 0.2. The differences were found to be statistically significant (P<0.05). We highly recommend the technique described here, which offers efficient analgesia and control of erection in adult hypospadias patients.
Br J Plast Surg 2002
Sep
PMID:Two in one: patient-controlled epidural analgesia (PCEA) to prevent erection and control pain in adult hypospadias-surgery patients. 1247 23
Continuous peripheral nerve blocks (CPNB) after pediatric major orthopedic surgery are not widely used. We conducted a prospective descriptive study to evaluate the effectiveness of disposable elastomeric pumps for CPNB in children. After inducing general anesthesia, 25 consecutive children scheduled for major orthopedic surgery received a 0.5-mL/kg bolus of a mixture of 1% lidocaine with epinephrine and 0.25% bupivacaine in axillary, femoral, or popliteal catheters. After surgery, disposable pumps with 0.2% ropivacaine were connected. Pump flows were adjusted to the patient's weight.
Postoperative pain
was evaluated using a visual analog scale or Children and Infants
Postoperative Pain
Scale scores at H1, H6, H12, H24, and H48, as well as amounts of rescue analgesia, adverse events, and motor and sensory block. An ambulation score for the children was also evaluated. Eleven popliteal, nine femoral, and five axillary continuous blocks were performed. All the blocks were effective for surgery. The mean total dose consumption of 0.2% ropivacaine was 10.1 mg/kg. Disposable pump flow varied from -9.61% to +8.6% compared with the theoretical one. Postoperative analgesia was excellent. The median of pain score was zero at each period studied. Sensory and motor block were noted at H1 and decreased from the sixth hour. No adverse events were noted. We concluded that the use of elastomeric disposable pumps for CPNB in children was an effective technique.
Anesth Analg 2003
Sep
PMID:Perioperative continuous peripheral nerve blocks with disposable infusion pumps in children: a prospective descriptive study. 1293 85
Surgery is associated with immune alterations, which are the combined result of tissue damage, anesthesia, postoperative pain, and psychological stress. In the present study, we compared the effects of several postoperative pain management techniques on postoperative immune function. Patients hospitalized for abdominal surgery were randomly assigned to one of three postoperative pain management techniques: opiates on demand (intermittent opiate regimen [IOR]), patient-controlled analgesia (PCA), and patient-controlled epidural analgesia (PCEA).
Postoperative pain
was assessed. Blood samples were collected before and 24, 48, and 72 h after surgery. Production of interleukin (IL)-1beta, IL-2, and IL-6, natural killer cell cytotoxicity, and lymphocyte mitogenic responses were assessed. Patients of the PCEA group exhibited lower pain scores in the first 24 h after surgery compared with patients of the IOR and PCA groups. Mitogenic responses were suppressed in all groups in the first 24 h, returned to preoperative values by 72 h in the PCEA group, but remained suppressed in the PCA group. Production of IL-1beta and IL-6 increased in the IOR and PCA groups, whereas it remained almost unchanged in the PCEA group. Patients receiving an epidural mixture of opiate and local anesthetics (PCEA group) exhibited reduced suppression of lymphocyte proliferation and attenuated proinflammatory cytokine response in the postoperative period.
Anesth Analg 2003
Sep
PMID:The effects of postoperative pain management on immune response to surgery. 1293 9
The authors evaluated the intraoperative data and early clinical results of 22 minimally invasive mini-incision total knee arthroplasties (mini-incision TKAs) performed between October 2002 and September 2003. Results were matched with 22 patients who underwent standard TKA in the same period. At a minimum 12-week follow up, results comparing the mini-incision TKA group and the standard TKA group were evaluated as follows: The average operative time was 137.1 vs 115.8min (p=0.02), the average wound length was 9.4 vs 13.7 cm, the average blood loss was 456 vs 512 ml (p=0.14) and the number of patients who could start to walk on postoperative day one was 17 vs 2. On postoperative day one, 82% of the mini-incision TKA group could do active knee extension meanwhile none of the standard group could.
Postoperative pain
score was not different at 24 hours or 48 hours. At 2 and6 weeks, the mini-incision TKA group had less pain with significant difference (p=0.002 and p=0.002). The postoperative range of motion in the mini-incision group was also significantly improved at 2 weeks (p=0.03). However, pain and range of motion were not different in both groups after 12 weeks. Early results of mini-incision TKA accelerated patient postoperative activity, ambulation and range of motion.
J Med Assoc Thai 2004
Sep
PMID:Rapid ambulation and range of motion after minimally invasive total knee arthroplasty. 1608 87
Postoperative pain
treatment is the challenge of the new century; we know that even starting from the 24(th) week of gestational age, the fetus can feel pain and that memory of uncontrolled pain can change the pain threshold in children. We have now new drugs and new tools for an optimal pain control also in children and this review is an update on the new therapies and devices which can help us in the daily clinical practice.
Minerva Anestesiol 2005
Sep
PMID:Update on postoperative analgesia in children. 1616 8
Although nonsteroidal antiinflammatory drugs (NSAIDs) improve postoperative pain relief after cesarean delivery, they carry potential side effects (e.g., bleeding). Perioperative cyclooxygenase (COX)-2 inhibitors show similar analgesic efficacy to nonsteroidal antiinflammatory drugs in many surgical models but have not been studied after cesarean delivery. We designed this randomized double-blind study to determine the analgesic efficacy and opioid-sparing effects of valdecoxib after cesarean delivery. Healthy patients undergoing elective cesarean delivery under spinal anesthesia were randomized to receive oral valdecoxib 20 mg or placebo every 12 h for 72 h postoperatively. As a result of cyclooxygenase-2 inhibitors safety concerns that became apparent during this study, the study was terminated early after evaluating 48 patients. We found no differences in total analgesic consumption between the valdecoxib and placebo groups (121 +/- 70 versus 143 +/- 77 morphine mg-equivalents, respectively; P = 0.26). Pain at rest and during activity were similar between the groups despite adequate post hoc power to have detected a clinically significant difference. There were also no differences in IV morphine requirements, time to first analgesic request, patient satisfaction, side effects, breast-feeding success, or functional activity.
Postoperative pain
was generally well controlled. Adding valdecoxib after cesarean delivery under spinal anesthesia with intrathecal morphine is not supported at this time.
Anesth Analg 2006
Sep
PMID:Valdecoxib for postoperative pain management after cesarean delivery: a randomized, double-blind, placebo-controlled study. 1693 78
We report a safe anesthetic management of patients with multiple sclerosis (MS) using sevoflurane. A 34-yr-old female patient with a 2-yr history of MS was scheduled for gynecological surgery. Anesthesia was induced with propofol and fentanyl and maintained with sevoflurane, nitrous oxide, and fentanyl. Vecuronium was used for tracheal intubation. The patient showed rapid emergence from anesthesia. Exacerbation of symptoms of MS was negative according to the neurologic assessment at that time.
Postoperative pain
was managed mainly with continuous venous infusion of fentanyl instead of neural block with local anesthetics. Transient fever due to subcutaneous infection of the surgical site was observed and topical drainage was required. Eventually, postoperative exacerbation of symptoms of MS compared with preoperative status did not appear. In conclusion, sevoflurane does not induce exacerbation of symptoms and facilitates early postoperative neurologic assessment, therefore, it is one of ideal anesthetics for MS patients.
Acta Anaesthesiol Taiwan 2006
Sep
PMID:Sevoflurane is safe for anesthetic management in patients with multiple sclerosis. 1703 9
Pain represents the most feared symptom of illness but for many years it has been underestimated in children. Only recently has analgesic treatment become an integral part in the assistance of ill children with acute pain, such as postoperative pain, and with chronic pain.
Postoperative pain
is a complication of surgery: postoperative pain prevention should replace the current theory and practice of postoperative treatment through the creation of ''pain services'' and adequate pain prevention planning. Pain prevention begins in the preoperative period, continues in the operating theaters and in the postoperative phase. A multimodal approach should employ techniques of loco-regional anesthesia using a variety of agents from opioids to nonsteroidal anti-inflammatory drugs or paracetamol. The techniques we currently use to control procedural pain are both medical and nonmedical. Nonmedical interventions such as distraction, muscular relaxation, and guided imagination for pain control are psychological techniques showing very good results in those children who must undergo various procedures. The medical treatment must guarantee both sedation and effective analgesia. Our medical approach includes local anaesthesia, conscious sedation, deep sedation, and general anaesthesia.
Minerva Anestesiol 2007
Sep
PMID:Methodologies for the treatment of acute and chronic nononcologic pain in children. 1766 Jul 39
<< Previous
1
2
3
4
5
6
7
8
Next >>